What is the dosing for gabapentin (Neurontin) for fibromyalgia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Gabapentin Dosing for Fibromyalgia

For fibromyalgia, gabapentin should be initiated at 300 mg at bedtime, gradually titrated to a target effective dose of 1800 mg/day (divided into 3 doses), with a maximum dose of 2400 mg/day if needed. 1

Initial Dosing and Titration Schedule

  • Starting dose: 300 mg at bedtime or 100-300 mg three times daily 1
  • Titration: Increase by 300 mg every 3-7 days as tolerated 1
  • Target effective dose: 1800 mg/day (600 mg three times daily) 1
  • Maximum dose: 2400 mg/day for fibromyalgia 2

Dosing Considerations

Efficacy and Risk Profile

  • 900-1800 mg/day: Effective for most patients with lower risk of adverse effects 1
  • 1800-2400 mg/day: Modest additional benefit with increased risk of adverse effects 1
  • 2400-3600 mg/day: Minimal additional benefit with significantly higher risk of falls, fractures, and edema 1

Evidence for Efficacy

  • In a randomized, double-blind, placebo-controlled trial, gabapentin at doses of 1200-2400 mg/day demonstrated significant improvement in pain scores compared to placebo 2
  • 51% of patients on gabapentin achieved at least 30% pain reduction compared to 31% on placebo 2
  • Cochrane review indicates limited evidence with only one high-quality study showing efficacy 3

Administration Guidelines

  • Frequency: Divide daily dose into three administrations to improve tolerability 1
  • Timing: Take with food to minimize side effects 1
  • Duration of trial: An adequate trial requires 3-8 weeks for titration plus 2 weeks at maximum dose before determining efficacy 1

Side Effect Management

  • Common side effects: Dizziness (19%), somnolence (14%), peripheral edema (7%), and gait disturbance (14%) 1
  • Minimizing side effects:
    • Start with lower dosages
    • Titrate cautiously
    • Take medication with food
    • Use nighttime dosing for sedating effects 1

Special Populations

  • Elderly patients: Start at lower doses (100-300 mg at bedtime) and titrate more slowly 1
  • Renal impairment: Dose adjustment required based on creatinine clearance 1
    • CrCl 30-59 mL/min: Maximum 700 mg at bedtime
    • CrCl 15-29 mL/min: Maximum 700 mg at bedtime
    • CrCl <15 mL/min: Maximum 300 mg at bedtime

Discontinuation

  • Taper gradually over at least 1 week to avoid withdrawal symptoms 1
  • Recommended tapering schedule:
    • 300 mg at bedtime for 1-3 days
    • 300 mg twice daily for 1-3 days
    • 300 mg three times daily before further reduction 1

Clinical Pearls

  • Gabapentin has nonlinear pharmacokinetics due to saturable absorption, necessitating divided dosing 1
  • While pregabalin has more robust evidence for fibromyalgia treatment 4, gabapentin remains a viable alternative
  • Extended-release gabapentin formulations may improve sleep quality and quantity in fibromyalgia patients 5
  • Consider that only about 10% more patients will achieve significant pain relief with gabapentin compared to placebo 3

References

Guideline

Gabapentin Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Gabapentin for fibromyalgia pain in adults.

The Cochrane database of systematic reviews, 2017

Research

Pregabalin for pain in fibromyalgia in adults.

The Cochrane database of systematic reviews, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.